eXp World Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that eXp World Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $500.15M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $156.10M | Mar 18, 2019 |
| FY2017 | Sep 30, 2017 | $47.37M | Apr 17, 2018 |
| FY2017 | Jun 30, 2017 | $38.98M | Apr 17, 2018 |
| FY2017 | Mar 31, 2017 | $21.53M | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $53.56M | Apr 17, 2018 |
| FY2017 | Sep 30, 2016 | $15.68M | Apr 17, 2018 |
| FY2017 | Jun 30, 2016 | $13.08M | Apr 17, 2018 |
| FY2017 | Mar 31, 2016 | $6.99M | Apr 17, 2018 |
| FY2017 | Dec 31, 2015 | $22.46M | Apr 17, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.77B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $4.27B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $4.59B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.77B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $609.32M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $564.02M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | $353.53M | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $271.42M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $274.02M | Mar 11, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $333.58M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $342.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $319.92M | Feb 24, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.71M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($21.27M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($8.97M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $15.44M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $81.22M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $31.13M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($9.53M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($22.43M) | Mar 11, 2021 |
| FY2018 | Dec 31, 2017 | ($22.13M) | Mar 18, 2019 |
| FY2017 | Sep 30, 2017 | ($5.31M) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.47M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($18.99M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $522.0K | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $16.36M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $34.15M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $31.59M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($8.78M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($22.38M) | Mar 11, 2021 |
| FY2018 | Dec 31, 2017 | ($22.03M) | Mar 18, 2019 |
| FY2017 | Sep 30, 2017 | ($5.31M) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.62M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $58.18M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $59.55M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $54.20M | Feb 20, 2025 |
| FY2013 | Jun 30, 2013 | $0 | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | $0 | Sep 27, 2013 |
| FY2011 | Jun 30, 2011 | $12.6K | Nov 4, 2011 |
| FY2011 | Jun 30, 2010 | $12.6K | Nov 4, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.61M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $191.51M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $209.13M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $210.54M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $246.89M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $119.66M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $55.19M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $24.31M | Mar 11, 2021 |
| FY2018 | Dec 31, 2017 | $4.57M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $1.02M | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.57M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $6.48M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $5.36M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $12.05M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $13.42M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $6.44M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $5.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.13M | Mar 11, 2021 |
| FY2018 | Dec 31, 2017 | $1.28M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $416.7K | Apr 17, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $442.48M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $390.72M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $385.67M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $381.68M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $413.83M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $242.19M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $96.45M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $55.85M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $14.64M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $6.10M | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $185.85M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $141.66M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $132.69M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $190.29M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $99.60M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $44.32M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $25.87M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $10.38M | Mar 18, 2019 |
| FY2014 | Dec 31, 2014 | $499.5K | Mar 31, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $242.78M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $204.87M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $242.84M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $247.82M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $222.17M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $141.58M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $51.97M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $29.98M | Mar 12, 2020 |
| FY2017 | Dec 31, 2017 | $4.26M | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $2.53M | Apr 17, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.87M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $17.23M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $16.98M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $27.21M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $12.95M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $12.95M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $8.25M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $8.25M | Mar 11, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($121.62M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($68.14M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($16.77M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $20.72M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $30.51M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($39.16M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($70.29M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($60.77M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($32.60M) | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | ($10.47M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.25M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $113.61M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $125.87M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $121.59M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $108.24M | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $100.14M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $40.09M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $20.54M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $4.67M | Mar 12, 2020 |
| FY2017 | Dec 31, 2016 | $1.68M | Apr 17, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $0 | Mar 16, 2016 |
| FY2015 | Dec 31, 2014 | $61.9K | Mar 16, 2016 |
| FY2014 | Dec 31, 2013 | $61.9K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $76.9K | Mar 21, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 161.05M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 154.13M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 154.67M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 152.84M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 148.76M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 144.14M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 131.47M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 60.61M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 54.96M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | 52.32M | Apr 17, 2018 |